ScholarIQanswers from OpenAlex

Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial

PaperCitations, authors & open-access status

Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial have?

ScholarIQcitation count

Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial has 83 citations in the OpenAlex counts ScholarIQ stores.

When was Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial published?

ScholarIQyear

Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial has 2017 year in the ScholarIQ index.

What is the open-access status of Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial?

ScholarIQoa status

Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial has gold oa status in the ScholarIQ index.

What is the DOI of Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial?

ScholarIQdoi

The DOI for Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial is on the source record.

What is the PMID of Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial?

ScholarIQpmid

The PMID for Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial is on the source record.

What is the OpenAlex record for Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial?

ScholarIQopenalex

The OpenAlex for Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial